P810: A NOVEL INDIRUBIN-3-MONOXIME DERIVATIVES FUNCTION AS DISRUPTORS OF PROTEOSTASIS VIA TARGETING TRIM28 IN MULTIPLE MYELOMA

Hemasphere · 2023 · PMC10430520

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Myeloma and other monoclonal gammopathies - Biology & Translational Research Background: Despite the availability of several novel therapies, multiple myeloma (MM) remains incurable, making the search for new therapeutic targets and treatments highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.